Argeris N. Karabelas, Director at Vanda Pharmaceuticals Inc. (VNDA), sold 237,500 shares at $12.65 ($3.0M) on 2009-10-13, disclosed to the SEC on 2009-10-15.
Open-market sale of $3.0M VNDA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RGNX | SELL | 2024-08-05 | $136K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |